The “BNT162b2” vaccine developed by Pfizer and BioNTec, is a so-called mRNA vaccine hurriedly developed and brought onto the market with conditional approval. Above all, this vaccine is fundamentally different from all other vaccines used to date.
The conditional approval is valid for one year and allows vaccinations to be started before the full clinical trial is complete.
The vaccine contains the genetic information for a protein that sits on the surface of Sars-CoV-2 and docks with the host cells of the vaccinated person. This genetic information serves as a blueprint with which the cells of the vaccinated are supposed to produce the virus protein, a product of a foreign organism.
The immune system is then supposed to recognize the foreign proteins produced by the body as “not endogenous” and to form antibodies and memory T-cells that destroy these proteins and immunize them against “Corona”. For this to work, the…
View original post 829 more words